A 28-year-old previously healthy female Thai native German resident reported a history of headache and fever with a singular wound for 5 weeks on the lower back after vacation in Bangkok/Thailand. The lesion was elevated with a cauliflower-like aspect (Fig. 1a). The patient reported local tenderness and denied night sweats or weight loss. The physical examination was otherwise unrevealing. Wound-swab cultures were obtained and empirical treatment started with ciprofloxacin 500 mg BID. Blood tests (CBC, CRP, ESR, basic liver- and retention parameters) were within normal limits. Serologically, no evidence for syphilis, Leishmania spp. or HIV. Swab cultures grew whitish wrinkled colonies on blood media which were identified with MALDI-TOF–MS1 [1] to be Burkholderia pseudomallei. AST2 demonstrated susceptibility against tetracycline, piperacillin and quinolones as well as ceftazidime. Resistance against cotrimoxazole, a possible treatment option was detected. Although the wound showed healing tendencies (Fig. 1b) after 7 days of ciprofloxacin treatment, regimen was changed to ceftazidime i.v. 40 mg/kg for 10 days and a follow up of 56 days of doxycycline 100mg BID. The skin closed completely and left a hyperpigmented scar (Fig. 1c). Immuno-Blot against B. pseudomallei LPS-Type-A was positive [2].
MALDI-TOF-MS: matrix assisted laser desorption/ionization time of flight mass spectrometry; the system used was the Bruker Microflex/Biotyper package with the regular and bioterror database.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.